Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Venrock Healthcare Capital Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners

Operating

Venrock Healthcare Capital Partners: A dedicated, data-driven investor supporting success in healthcare.

Location
New York City, NY, US
Founded
1969
Firm
Compare
Portfolio
Employees

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies.

It leverages its venture expertise, rigorous data analysis, and long-term supportive orientation to support successful biotechnology companies within the public markets.

Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments19
Current Portfolio Count17
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity7 (36.8%)
Series B5 (26.3%)
Series C5 (26.3%)
Series A1 (5.3%)
Series E1 (5.3%)

Stage Mix

Post Ipo Equity 37%Series B 26%Series C 26%Series A 5%Series E 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Astria Therapeutics logo

Astria Therapeutics

Taysha Gene Therapies logo

Taysha Gene Therapies

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

Upstream Bio logo

Upstream Bio

Lyra Therapeutics logo

Lyra Therapeutics

Carmot Therapeutics logo

Carmot Therapeutics

Lusaris Therapeutics logo

Lusaris Therapeutics

Terns Pharmaceuticals logo

Terns Pharmaceuticals

Mythic Therapeutics logo

Mythic Therapeutics

Whitehawk Therapeutics logo

Whitehawk Therapeutics

Artiva Biotherapeutics logo

Artiva Biotherapeutics

Cullinan Oncology logo

Cullinan Oncology

Cogent Biosciences logo

Cogent Biosciences

Devoted Health logo

Devoted Health

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Sojournix logo

Sojournix

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

Similar Investment Firms

Venrock logo

Venrock

GT Healthcare Capital Partners logo

GT Healthcare Capital Partners

Varsity Healthcare Partners logo

Varsity Healthcare Partners

Prox Ventures logo

Prox Ventures

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Health Velocity Capital logo

Health Velocity Capital

Venture Equity Partners logo

Venture Equity Partners

Versant Ventures logo

Versant Ventures

MPM Capital logo

MPM Capital

mpmbioimpact.com

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

Regal Healthcare Capital Partners logo

Regal Healthcare Capital Partners

regalhcp.com

Vectis Healthcare & Life Sciences Fund logo

Vectis Healthcare & Life Sciences Fund

WindRose Health Investors logo

WindRose Health Investors

windrose.com

Health2047 Capital Partners logo

Health2047 Capital Partners

Foresite Capital logo

Foresite Capital

Venrock Healthcare Capital Partners - Classification

Also Known As
  • Venrock Healthcare Capital Partners LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end